Luigina Ferrigno - Publications

Risk profiles for acute hepatitis B and C from 2004 to 2024 in Italy: A cluster and disproportionality analysis from the SEIEVA registry.

Journal: The Journal of infection

Published: November 06, 2025

Sex-based differences in hepatitis delta virus infection: Insights from the Italian PITER hepatitis delta virus cohort.

Journal: World journal of gastroenterology

Published: July 07, 2025

ITA-MASLD: A national observational study to characterize the profile of patients with MASLD in specialistic care in Italy.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: June 03, 2025

Reduction of the Risk of Hepatocellular Carcinoma over Time Using Direct-Acting Antivirals: A Propensity Score Analysis of a Real-Life Cohort (PITER HCV).

Journal: Viruses

Published: March 28, 2024

Impact of the COVID-19 pandemic on the Italian national viral hepatitis surveillance: an interrupted time series analysis, 2006-2022.

Journal: Public health

Published: December 01, 2023

Predicting de-novo portal vein thrombosis after HCV eradication: A long-term competing risk analysis in the ongoing PITER cohort.

Journal: United European gastroenterology journal

Published: August 13, 2023

Reply to: Comments on "Risk of parenterally transmitted hepatitis following exposure to invasive procedures in Italy: SEIEVA surveillance 2000-2021".

Journal: Journal of hepatology

Published: July 11, 2023

Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: November 14, 2022

Profiling the risk of hepatocellular carcinoma after long-term HCV eradication in patients with liver cirrhosis in the PITER cohort.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: October 20, 2022

Pneumococcal vaccination status among cirrhotic patients in Italy: a neglected topic.

Journal: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

Published: October 07, 2022

COVID-19 vaccination among cirrhotics in Italy: High coverage and effectiveness of 3 doses versus 2 in preventing breakthrough infection and hospitalization.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: September 30, 2022

Risk of parenterally transmitted hepatitis following exposure to invasive procedures in Italy: SEIEVA surveillance 2000-2021.

Journal: Journal of hepatology

Published: August 05, 2022